Maxim., one of the most frequently used traditional Chinese medicines for thousands of years, is prescribed as having "bone strengthening" function and the ability to cure bone diseases. The present study evaluated the osteogenic effects of anhydroicaritin (1) and 2″-hydroxy-3″-enanhydroicaritin (2) isolated from E. brevicornu by activity-guided assay. Treatment with1 and 2 improved the proliferation of murine osteoblastic MC3T3-E1 cells at doses of 10 -7 -10 -5 mol/L and 10 -7 -10 -6 mol/L, respectively, in the 72-hour culture period. Enzyme linked immunosorbent assay and histochemical staining demonstrated that both of these two prenyl-flavonoids significantly promoted the differentiation of MC3T3-E1 cells by enhancing the level of ALP activity in the cells. Alizarin Red staining and mineralized nodule quantification showed that 1 and 2 had the potential of stimulating the formation of mineralization nodules and further speeding up the formation of bone, indicating that both compounds might be potential candidates for bone regenerative medicine.
Bone defects result from congenital or acquired factors like trauma, tumor resection, arthroplasty and other diseases that might cause serious dysfunction and deformity [1] . The treatment of serious bone defects has always been a challenging problem in orthopedics. Tissue engineering based on osteoconductive scaffolds, cells and osteogenic growth factors has gained in interest in order to overcome difficult bone problems. Osteogenic growth factors, like bone morphogenetic proteins, have demonstrated an impressive ability to induce new bone formation. However, the large amount of bone morphogenetic proteins (BMPs) increases the risk of ectopic bone formation [2] . In addition, the high cost and rapid degradation of BMPs and other protein drugs also limit their clinical use [2a,3] . Epimedium brevicornu Maxim. is one of the most frequently used Chinese herbs that has been used for thousands of years in formulas prescribed for the nourishment of bone and gonadal functions [4] . Previous studies showed that oral or intragastric administration of extracts of E. brevicornu to rats with osteoporosis can dramatically improve the femur dry weight, femoral ash weight and the calciumand phosphorus contents of bone [2a,4b] . Recent research reported that epimedin B and epimedin C from E. brevicornu could stimulate the proliferation of primary osteoblasts and UMR106 cells [5] . Studies on icariin, icaritin and desmethylicaritin showed beneficial effect on preventing bone loss [6] . However, these reported compounds only accounted for a small part of the total effective constituents, and more studies were needed to investigate on the osteogenic compounds in E. brevicornu. Therefore, this study was aimed at deriving effective constitutions with osteogenic activity from E. brevicornu by using bio-guided assay. Two prenylflavonoids, anhydroicaritin (1) and 2″-hydroxy-3″-en-anhydroicaritin (2), were isolated from the main effective fraction (CHCl 3 -Me 2 CO, 7:3 part) and proved, for the first time, to have the ability to promote proliferation and differentiation of murine osteoblastic MC3T3-E1 cells.
The EtOAc fraction of the 70% aqueous acetone extracts (B) was more active than the CHCl 3 (A), n-BuOH (C), and H 2 O fractions (D) (Figure 2. ). Further studies evaluated the five fractions A-E from B (Table 1) . Fr. B4 (CHCl 3 -Me 2 CO, 7:3 of B) promoted proliferation of osteoblasts, and had the strongest stimulation effect of all the fractions at a concentration of 1.0×10 -3 mg/mL. Alkaline phosphatase (ALP) activity was determined as a marker for the early maturation and differentiation of the MC3T3-E1 cells [7] . Fr. B4 not only promoted cell proliferation, but also significantly stimulated differentiation of osteoblast-like cells at all concentrations, without large fluctuation, and dose-dependently (Table 1) .
Bioassay-guided fractionation of Fr. B4 led to the isolation and purification of anhydroicaritin (1) and 2"-hydroxy-3"-en-anhydroicaritin (2); their structures were identified by comparison of their physical properties and spectral data ( 1 H NMR, 13 C NMR, and EI-MS) with literature values [8] . We examined concentrations of 0 and10 -5 -10 -9 mol/L of 1 and 2 on three day old cultures, but the 10 -7 -10 -9 mol/L concentrations showed the same tendency (data not shown), therefore, we only chose the concentration range of 0 and 10 -5 -10 -7 mol/L to evaluate the effect of the two compounds. As seen in Figure3, 1 stimulated proliferation of the MC3T3-E1 cells in the range of 10 -5 -10 -7 mol/L, and 2 at concentrations of 10 -7 and NPC Natural Product Communications 2012 Vol. 7 No. 11 1461 -1464 and 10 -6 mol/L in the 72-hour culture period (p < 0.05). At the concentration of 10 -6 mol/L, the viability of osteoblasts treated with 1 and 2, respectively was 17.0% and 14.2% higher than the control.
The effects of 1 and 2 on osteoblastic differentiation were tested by measuring ALP activity and histochemical staining. As shown in Figure 4E , after 7 days of culture, treatment with 1 produced 146% higher ALP activity than the control group (p < 0.05) and 37.6% higher than the positive group (p< 0.05). With compound 2, the corresponding values were 82.6% (p < 0.05) and 2.1%, respectively. The results were confirmed by ALP staining, which manifested significant differences between the experimental and control groups. Far more cells were stained dark blue in the 1 and 2 treatment groups than in the control group (Figure 4.) .
Compounds 1 and 2 were further evaluated for the formation of mineralized nodules by alizarin staining. Mineralization is considered a functional in vitro endpoint reflecting advanced cell differentiation [9] . The mineralized nodule formation assay on day 21 revealed that there were far more mineralized nodules with larger areas in the 1 and 2 treatment groups than in the osteogenic . For the duration of the osteoblasts' maturation, the alkaline phosphatase (ALP) secretion by osteoblasts significantly increased when stimulated with osteogenic medium, the experimental medium for 1 and 2 (E). Data shown as mean±SEM; n =3; *p< 0.05. medium group. Quantification of the calcium content showed that the OD values for both experimental groups were much higher than those of the control (p< 0.001) and osteogenic medium groups (p< 0.01) ( Figure 5 ), which indicated that 1 and 2 had stimulated the formation of mineralized nodules.
In previous studies, more than 260 compounds have been identified from different species of Epimedium [10] . Among these, prenyl-flavonoids are the major constituents and also important chemotaxonomic markers [11] . Existing research illustrates that prenyl-flavonoids like icariin (3) manifest strong ability to improve osteoblast differentiation, mineralization and exert better effects in either preserving bone mass or preventing bone loss [6b,12] . Structure-activity relationship studies showed that the prenyl group on C-8 may be highly related to the osteogenic activity [13] . Icariin (3) has stronger osteogenic activity than genistein, which might be due to the prenyl group on C-8, since the C-3 rhamnosyl group, C-7 gluosyl group, and C-4 methoxyl group are not necessary for osteogenic activity [13a] . In our study, the two prenyl-flavonoids (1 and 2) possess the same carbocyclic skeleton and prenyl group on C-8 as icariin, which implies that they should have the capability of enhancing proliferation, osteogenic differentiation, and mineralization.
Bioassay-guided fractionation successfully connects chemical separation and activity for screening the real active principles in plants [14] . Such bioactive-guided fractionation allowed us to identify two prenyl-flavonoids, both of which were proved to have functions related to the stimulation of bone formation. This implied that the activity of the studied Epimedium species might be related to these flavonoids.
In summary, the crude extract of E. brevicornu and two prenylflavonoids, anhydroicaritin and 2″-hydroxy-3″-en-anhydroicaritin, stimulate the proliferation anddifferentiation of MC3T3-E1, which suggested that both compounds have the potential to be candidates for osteogenic compounds for bone regenerative medicine. Future studies should focus on the basic mechanisms of anhydroicaritin and 2″-hydroxy-3″-en-anhydroicaritin governing proliferation and differentiation of osteoblast cells.
Experimental

Extraction and isolation by bio-guided assay:
The whole plants of E. brevicornu were purchased at the Juhuacun herb market, Kunming, Yunnan, People's Republic of China, in September 2006, and were identified by Dr. Hai-zhou Li. A voucher specimen (KMUST 2006091101) was deposited at the Laboratory of Phytochemistry, Faculty of Life Science and Technology, Kunming University of Science and Technology. The air-dried and powdered whole parts of E. brevicornu (1200 g) were extracted with 70% aqueous acetone (6L×6) at room temperature and filtered. The filtrate was evaporated in vacuo at 55 o C to afford a residue (97g), which was suspended in H 2 O (1L), and then extracted with CHCl 3 (1 L), EtOAc (1 L) and n-BuOH (1 L), respectively, to afford 4 parts, CHCl 3 (A 12.4g), EtOAc (B 35.6g), n-BuOH (C 33.9g), and H 2 O (D 4.7g). The bioactive EtOAc part (35.6 g) was then purified by CC over silica gel (CHCl 3 -Me 2 CO, 1:0, 9:1, 8:2, 7:3, 6 :4 and 1:1) to yield 6 fractions, Fr. B1-B6. These were tested in experimental cell models (Tables 1 and 2) , and the bioactive Fr. B4 (3.2 g, CHCl 3 -Me 2 CO 7:3) was subjected to CC over silica gel and Sephadex LH-20 to yield two prenyl-flavonoids 1 (4 mg) and 2 (2.5 mg) (Figure 1.) .The contribution ratio of compounds 1 and 2 in the plant extract was 0.0041% and 0.0026%, respectively, while, in the EtOAc fraction, it was 0.011% and 0.007%, respectively.
Cell culture: Mouse calvaria-derived, pre-osteoblastic cells, MC3T3-E1, were purchased from China Cell Line Bank (Beijing, China) and cultured in α-MEM (Gibco, Paisley, UK) containing 10% fetal bovine serum (FBS) (Gibco, Paisley, UK) and 1% penicillin/streptomycin (Sigma-Aldrich) as "control medium" (CON) in a humidified atmosphere of 5% CO 2 at 37°C. To induce differentiation into the mature osteoblasts, an "osteogenic medium" (OS) was prepared by adding 50 µg/mL ascorbic acid, 10 mMβglycerophosphate, and 50 nM dexamethasone into the "control medium" as positive control. An "experimental medium" was prepared by adding different quantities of either E. brevicornu extracts or compounds.
Cell proliferation assays: MC3T3-E1 cells were seeded in 96-well plates at a density of 6000 cells/well. After 24 h, the medium was changed to experimental medium with concentration of 10 -5 , 10 -6 and 10 -7 mol/L. After a 72-h incubation period, 10 µL of WST-8 {SF (Nacalai Tesque, Kyoto, Japan), 2-(2-methoxy-4-nitro-phenyl)-3-(4-nitrophenyl)-5-(2, 4-disulfophenyl)-2H-tetrazolium, monosodium salt} solution was added to each well. Then, the cells were incubated at 37 o C for 2 h. The absorbance at 450 nm in each well was determined by using a microplate reader (Bio-Rad 680, Microplate Master, Hercules, CA, USA).
Alkaline phosphatase (ALP) activity assay:
Cells were stimulated with osteogenic medium (as positive control) and experimental medium for 7 days at a density of 1 × 10 5 cells/well in a 24-well plate. ALP activity of the lysate was determined with pnitrophenylphosphate (pNPP; Wako, Osaka, Japan) by using the Lowry method. After 30 min incubation at 37°C, absorbance of pNPP at 405 nm was measured using a microplate reader. Protein contents were determined using a BCA protein assay kit (MicroBCA, Protein Assay Kit, Pierce, Rockford, IL, USA). The value of ALP activity was calculated as nmol/min protein.
Histochemical staining: For ALP staining, after stimulation for 7 day, cells were fixed with 70% ethanol, rinsed with deionized water, and treated with a BCIP/NBT solution (Sigma Aldrich, St. Louis, MO) for 30 min. Then, the excess dye was washed with deionized water and the stained cells were photographed.
